目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED AND REGIONAL SCOPE
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.2 MARKET ESTIMATION METHODOLOGY
2.2.1 MARKET SIZE ESTIMATION
2.2.2 INSIGHTS FROM PRIMARY EXPERTS
2.2.3 TOP-DOWN APPROACH
2.3 MARKET GROWTH RATE PROJECTION
2.4 DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 SYNTHETIC BIOLOGY MARKET OVERVIEW
4.2 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION AND COUNTRY (2023)
4.3 SYNTHETIC BIOLOGY MARKET SHARE, BY APPLICATION, 2024 VS. 2029
4.4 SYNTHETIC BIOLOGY MARKET, BY REGION

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Diverse applications of synthetic biology
5.2.1.2 Surging demand for bio-based products
5.2.1.3 Advancements in synthetic biology
5.2.1.4 Increasing funding in R&D and collaborations
5.2.2 RESTRAINTS
5.2.2.1 Production scalability
5.2.2.2 Ethical and regulatory challenges
5.2.3 OPPORTUNITIES
5.2.3.1 Rising opportunities for agricultural synthetic biology
5.2.3.2 Growing integration of artificial intelligence and machine learning
5.2.4 CHALLENGES
5.2.4.1 Cost constraints
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.5.1 PRODUCT/SERVICE PROVIDERS
5.5.2 END USERS
5.5.3 REGULATORY LANDSCAPE
5.6 TECHNOLOGY ANALYSIS
5.6.1 KEY TECHNOLOGIES
5.6.1.1 DNA synthesis and sequencing
5.6.1.2 Gene editing tools
5.6.1.3 Bioinformatics and computational tools
5.6.1.4 Nanotechnology
5.6.2 COMPLEMENTARY TECHNOLOGIES
5.6.2.1 Cellular and tissue engineering
5.6.3 ADJACENT TECHNOLOGIES
5.6.3.1 Metabolic engineering
5.7 PATENT ANALYSIS
5.7.1 METHODOLOGY
5.7.2 NUMBER OF PATENTS FILED
5.7.3 INNOVATION AND PATENT APPLICATIONS
5.8 PRICING ANALYSIS
5.8.1 INDICATIVE PRODUCT PRICING ANALYSIS, BY KEY PLAYER
5.8.2 INDICATIVE PRODUCT PRICING ANALYSIS, BY REGION
5.9 KEY CONFERENCES & EVENTS, 2024-2025
5.10 REGULATORY LANDSCAPE
5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.10.2 REGULATORY FRAMEWORK
5.11 INVESTMENT & FUNDING SCENARIO
5.12 PORTER'S FIVE FORCES ANALYSIS
5.12.1 INTENSITY OF COMPETITIVE RIVALRY
5.12.2 BARGAINING POWER OF SUPPLIERS
5.12.3 BARGAINING POWER OF BUYERS
5.12.4 THREAT OF SUBSTITUTES
5.12.5 THREAT OF NEW ENTRANTS
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY BUYING CRITERIA
5.14 IMPACT OF AI ON SYNTHETIC BIOLOGY MARKET

6 SYNTHETIC BIOLOGY MARKET, BY TOOL
6.1 INTRODUCTION
6.2 OLIGONUCLEOTIDES & SYNTHETIC DNA
6.2.1 SURGING DEMAND FOR SYNTHETIC GENES TO SUPPORT MARKET GROWTH
6.3 ENZYMES
6.3.1 WIDE POTENTIAL OF ENZYME ENGINEERING IN OMICS STUDIES TO PROPEL MARKET
6.4 CLONING TECHNOLOGY KITS
6.4.1 ALTERATION AND OPTIMIZATION OF GENETIC CIRCUIT DESIGNS BY MOLECULAR BIOLOGY TECHNIQUES TO DRIVE MARKET
6.5 SYNTHETIC CELLS
6.5.1 GROWING POPULARITY OF SYNTHETIC CELLS AS SUBSTITUTES FOR NATURAL CELLS TO BOOST MARKET GROWTH
6.6 CHASSIS ORGANISMS
6.6.1 INCREASING DEMAND FOR FOSSIL FUELS TO PROPEL MARKET
6.7 XENO NUCLEIC ACIDS
6.7.1 SPIKE IN DEMAND FOR BREAKTHROUGH MEDICINES TO AID MARKET GROWTH

7 SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
7.2 GENE SYNTHESIS
7.2.1 RISING DEMAND FOR SYNTHETIC GENES AND INCREASING COMPETITIVENESS AMONG MARKET PLAYERS TO SPUR MARKET GROWTH
7.3 GENOME ENGINEERING
7.3.1 SURGING NEED FOR RAPID, CHEAP, AND MULTIPLEX MODIFICATION OF GENOMES TO DRIVE MARKET
7.4 SEQUENCING
7.4.1 RISING ADOPTION OF SEQUENCING TECHNOLOGY TO BOOST MARKET GROWTH
7.5 BIOINFORMATICS
7.5.1 INCREASING ADVANCEMENTS AND RISING USE OF BIOINFORMATICS TO PROPEL MARKET GROWTH
7.6 CLONING
7.6.1 PRECISE GENETIC REPLICATION TO ACCELERATE RESEARCH AND SCALING APPLICATIONS ACROSS VARIOUS INDUSTRIES
7.7 SITE-DIRECTED MUTAGENESIS
7.7.1 WIDE APPLICATIONS IN GENETIC ENGINEERING, DNA ASSEMBLY, AND CLONING TECHNOLOGIES TO DRIVE MARKET
7.8 MEASUREMENT & MODELING
7.8.1 INCREASING DEMAND FOR CELL-FREE SYNTHETIC BIOLOGY TO FOSTER MARKET GROWTH
7.9 MICROFLUIDICS
7.9.1 RISING FOCUS ON INCREASING SCALABILITY OF SYNTHETIC BIOLOGY TOOLS TO PROPEL MARKET GROWTH
7.10 NANOTECHNOLOGY
7.10.1 CONVERGENCE BETWEEN SYNTHETIC BIOLOGY AND NANOTECHNOLOGY TO AID MARKET GROWTH

8 SYNTHETIC BIOLOGY MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 MEDICAL APPLICATIONS
8.2.1 PHARMACEUTICALS
8.2.1.1 Potential of synthetic biology techniques in development of active pharmaceutical ingredients to drive market
8.2.2 DRUG DISCOVERY & THERAPEUTICS
8.2.2.1 Cancer detection & diagnostics
8.2.2.1.1 Increasing investments in cancer research to support market growth
8.2.2.2 Other drug discovery & therapeutic applications
8.2.3 ARTIFICIAL TISSUE & TISSUE REGENERATION
8.2.3.1 Biosynthesis
8.2.3.1.1 Expansive design space enabled by synthetic biology to foster market growth
8.2.3.2 Stem cell regulation
8.2.3.2.1 Stem cell research to accelerate market growth
8.2.3.3 Other artificial tissue & tissue regeneration applications
8.3 INDUSTRIAL APPLICATIONS
8.3.1 BIOFUELS & RENEWABLE ENERGY
8.3.1.1 Advantages of using genetically engineered organisms for synthetic production of biofuels to propel market growth
8.3.2 INDUSTRIAL ENZYMES
8.3.2.1 Textile industry
8.3.2.1.1 Surge in demand for increasing reaction rates and reducing costs to foster market growth
8.3.2.2 Paper industry
8.3.2.2.1 Increasing use of enzymes in pulp and paper industry to favor market growth
8.3.2.3 Consumer care industry
8.3.2.3.1 Skincare & cosmetics
8.3.2.3.1.1 Benefits offered by synthetic biology technologies in manufacturing of skincare and cosmetic products to propel market growth
8.3.2.3.2 Other consumer care products
8.3.2.4 Other industries
8.3.3 BIOMATERIALS & GREEN CHEMICALS
8.3.3.1 Production of green chemicals through microbial fermentation to drive market
8.4 FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS
8.4.1 FLAVORS & FRAGRANCES
8.4.1.1 Rising demand for natural, sustainable products to bolster market growth
8.4.2 OTHER FOOD, ANIMAL HEALTH, AND AGRICULTURAL APPLICATIONS
8.5 ENVIRONMENTAL APPLICATIONS
8.5.1 BIOREMEDIATION
8.5.1.1 Increasing need for cost-effective, on-site environmental monitoring methods to boost market
8.5.2 BIOSENSING
8.5.2.1 Growing interest in development of whole-cell biosensors to drive market

9 SYNTHETIC BIOLOGY MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
9.2.2 US
9.2.2.1 Rising investment in synthetic biology companies and surging demand for bio-based products to drive market
9.2.3 CANADA
9.2.3.1 Strong research infrastructure and availability of funding to support market growth
9.3 EUROPE
9.3.1 EUROPE: MACROECONOMIC OUTLOOK
9.3.2 GERMANY
9.3.2.1 Government initiatives and increasing funding to propel market growth
9.3.3 UK
9.3.3.1 Increasing R&D expenditure to favor market growth
9.3.4 FRANCE
9.3.4.1 Investments aimed at increasing research in various biomedical fields to augment market growth
9.3.5 SWITZERLAND
9.3.5.1 Established biotech ecosystem, strong academic institutions, and favorable government policies to favor market growth
9.3.6 DENMARK
9.3.6.1 Presence of third-largest commercial drug development pipeline in Europe to favor market growth
9.3.7 ITALY
9.3.7.1 Increasing life sciences R&D funded by both public and private organizations to foster market
9.3.8 SPAIN
9.3.8.1 Well-established network of research centers, universities, and hospitals to support market growth
9.3.9 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
9.4.2 CHINA
9.4.2.1 Rising growth opportunities for pharmaceutical and biopharmaceutical companies to drive market
9.4.3 JAPAN
9.4.3.1 Growing awareness of synthetic biology's importance and potential applications to accelerate market growth
9.4.4 INDIA
9.4.4.1 Increasing R&D activities and government funding initiatives to bolster market growth
9.4.5 AUSTRALIA
9.4.5.1 Increasing funding for synthetic biology research to accelerate market growth
9.4.6 SOUTH KOREA
9.4.6.1 Increasing focus on developing biotechnology and pharmaceutical sectors to boost market
9.4.7 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
9.5.2 BRAZIL
9.5.2.1 Growing life sciences and pharmaceutical industry to fuel demand for synthetic biological products
9.5.3 MEXICO
9.5.3.1 Increasing support for biotechnology infrastructure development to augment market growth
9.5.4 REST OF LATIN AMERICA
9.6 MIDDLE EAST
9.6.1 MIDDLE EAST: MACROECONOMIC OUTLOOK
9.6.2 GCC COUNTRIES
9.6.2.1 KSA
9.6.2.2 UAE
9.6.2.3 Rest of GCC countries
9.6.3 REST OF MIDDLE EAST
9.7 AFRICA
9.7.1 AFRICA: MACROECONOMIC OUTLOOK

10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN SYNTHETIC BIOLOGY MARKET
10.3 REVENUE ANALYSIS
10.4 MARKET SHARE ANALYSIS
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
10.5.5.1 Company footprint
10.5.5.2 Region footprint
10.5.5.3 Tool footprint
10.5.5.4 Technology footprint
10.5.5.5 Application footprint
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
10.7 COMPANY VALUATION & FINANCIAL METRICS, 2023
10.7.1 FINANCIAL METRICS
10.7.2 COMPANY VALUATION
10.8 BRAND/PRODUCT COMPARISON
10.9 COMPETITIVE SCENARIO
10.9.1 PRODUCT LAUNCHES
10.9.2 DEALS
10.9.3 EXPANSIONS

11 COMPANY PROFILES
11.1 KEY PLAYERS
11.1.1 THERMO FISHER SCIENTIFIC INC.
11.1.1.1 Business overview
11.1.1.2 Products/Services offered
11.1.1.3 Recent developments
11.1.1.3.1 Product launches
11.1.1.3.2 Deals
11.1.1.3.3 Expansions
11.1.1.4 MnM view
11.1.1.4.1 Key strengths
11.1.1.4.2 Strategic choices
11.1.1.4.3 Weaknesses & competitive threats
11.1.2 MERCK KGAA
11.1.2.1 Business overview
11.1.2.2 Products/Services offered
11.1.2.3 Recent developments
11.1.2.3.1 Deals
11.1.2.4 MnM view
11.1.2.4.1 Key strengths
11.1.2.4.2 Strategic choices
11.1.2.4.3 Weaknesses & competitive threats
11.1.3 NOVOZYMES A/S
11.1.3.1 Business overview
11.1.3.2 Products/Services offered
11.1.3.3 Recent developments
11.1.3.3.1 Product launches
11.1.3.3.2 Deals
11.1.3.4 MnM view
11.1.3.4.1 Key strengths
11.1.3.4.2 Strategic choices
11.1.3.4.3 Weaknesses & competitive threats
11.1.4 EUROFINS SCIENTIFIC
11.1.4.1 Business overview
11.1.4.2 Products/Services offered
11.1.5 AGILENT TECHNOLOGIES INC.
11.1.5.1 Business overview
11.1.5.2 Products/Services offered
11.1.5.3 Recent developments
11.1.5.3.1 Products launches
11.1.5.3.2 Deals
11.1.5.3.3 Expansions
11.1.6 AMYRIS, INC.
11.1.6.1 Business overview
11.1.6.2 Products/Services offered
11.1.6.3 Recent developments
11.1.6.3.1 Deals
11.1.7 CODEXIS, INC.
11.1.7.1 Business overview
11.1.7.2 Products/Services offered
11.1.7.3 Recent developments
11.1.7.3.1 Product launches
11.1.7.3.2 Deals
11.1.7.3.3 Expansions
11.1.8 TWIST BIOSCIENCE
11.1.8.1 Business overview
11.1.8.2 Products/Services offered
11.1.8.3 Recent developments
11.1.8.3.1 Product launches
11.1.8.3.2 Deals
11.1.8.3.3 Expansions
11.1.9 GENSCRIPT
11.1.9.1 Business overview
11.1.9.2 Products/Services offered
11.1.9.3 Recent developments
11.1.9.3.1 Product launches
11.1.9.3.2 Deals
11.1.9.3.3 Other developments
11.1.10 PRECIGEN
11.1.10.1 Business overview
11.1.10.2 Products/Services offered
11.1.11 GINKGO BIOWORKS
11.1.11.1 Business overview
11.1.11.2 Products/Services offered
11.1.11.3 Recent developments
11.1.11.3.1 Product launches
11.1.11.3.2 Deals
11.1.12 VIRIDOS
11.1.12.1 Business overview
11.1.12.2 Products/Services offered
11.1.12.3 Recent developments
11.1.12.3.1 Product launches
11.1.12.3.2 Deals
11.1.12.3.3 Other developments
11.1.13 SYNTHEGO
11.1.13.1 Business overview
11.1.13.2 Products/Services offered
11.1.13.3 Recent developments
11.1.13.3.1 Product launches
11.1.13.3.2 Deals
11.1.13.3.3 Expansions
11.1.14 CREATIVE ENZYMES
11.1.14.1 Business overview
11.1.14.2 Products/Services offered
11.1.15 CYRUS BIOTECHNOLOGY
11.1.15.1 Business overview
11.1.15.2 Products/Services offered
11.1.15.3 Recent developments
11.1.15.3.1 Deals
11.2 OTHER PLAYERS
11.2.1 ATUM
11.2.2 TESELAGEN
11.2.3 ARZEDA
11.2.4 INTEGRATED DNA TECHNOLOGIES, INC.
11.2.5 NEW ENGLAND BIOLABS
11.2.6 ELEVATEBIO
11.2.7 ZENFOLD (IOSYNTH)
11.2.8 SYNBIO TECHNOLOGIES
11.2.9 INSCRIPTA, INC.
11.2.10 CRISPR THERAPEUTICS

12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS